A vaccine is a medical product primarily designed to stimulate antibodies against an infectious disease which help to improve the immunity of the target body.
Rising consumer awareness regarding health coupled with rising disposable income is expected to propel demand for infectious vaccines over the next seven years. Furthermore, increasing government activities to control epidemic diseases such as polio, camp fever, and swine flu is projected to have impact market growth significantly over the next seven years.

The global Infectious Vaccines market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Infectious Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Infectious Vaccines market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Infectious Vaccines in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Infectious Vaccines manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
CSL Limited (Australia)
Bavarian Nordic (Denmark)
GlaxoSmithKline plc. (U.K.)
Emergent Bio Solutions Inc. (US)
MedImmune LLC (US)
Johnson and Johnson (US)
Novartis AG (Switzerland)
Merck and Company (US)
Sanofi Pasteur (France)
Pfizer Inc. (US)

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Preventive vaccine
Therapeutic vaccine

Segment by Application
Adults
Pediatrics